KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy …
âThere have been few treatment advances for patients with malignant pleural mesothelioma, which can be challenging to treat through surgery and radiation alone,â said Dr. Quincy Chu, CCTG’s study chair of the IND.227 trial/KEYNOTE-483 trial.
See Original Article

Leave a Reply